Variant report
Variant | esv3481710 |
---|---|
Chromosome Location | chr9:101307131-101313629 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:11)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:11 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr9:101299125..101300704-chr9:101305712..101307766,2 | K562 | blood: | |
2 | chr9:101305246..101310158-chr9:101310437..101314302,6 | K562 | blood: | |
3 | chr9:101313147..101314853-chr9:101446937..101449701,2 | MCF-7 | breast: | |
4 | chr9:101306147..101307705-chr9:101312310..101313945,2 | K562 | blood: | |
5 | chr9:101305246..101310158-chr9:101310437..101314302,6 | K562 | blood: | |
6 | chr9:101302083..101304339-chr9:101306203..101307939,2 | K562 | blood: | |
7 | chr9:101306147..101307705-chr9:101312310..101313945,2 | K562 | blood: | |
8 | chr9:101304068..101307864-chr9:101310405..101312317,3 | MCF-7 | breast: | |
9 | chr9:101304068..101307864-chr9:101310405..101312317,3 | MCF-7 | breast: | |
10 | chr9:101297663..101300259-chr9:101312178..101315523,3 | MCF-7 | breast: | |
11 | chr9:101290759..101293528-chr9:101305877..101308434,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs538252576 | chr9:101307154-101307155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs558139715 | chr9:101307183-101307184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs186019658 | chr9:101307212-101307213 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
4 | rs10819042 | chr9:101307334-101307335 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs553960458 | chr9:101307375-101307376 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
6 | rs574220690 | chr9:101307392-101307393 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
7 | rs143075188 | chr9:101307409-101307410 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
8 | rs529420232 | chr9:101307459-101307460 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
9 | rs369851672 | chr9:101307552-101307553 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
10 | rs542841009 | chr9:101307590-101307591 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
11 | rs73490405 | chr9:101307606-101307607 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs116315608 | chr9:101307622-101307623 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
13 | rs138672661 | chr9:101307637-101307638 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
14 | rs563703548 | chr9:101307644-101307645 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
15 | rs140577656 | chr9:101307654-101307655 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
16 | rs557584091 | chr9:101307733-101307734 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
17 | rs74624798 | chr9:101307750-101307751 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
18 | rs559988687 | chr9:101307813-101307814 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs529127379 | chr9:101307828-101307829 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs548865363 | chr9:101307913-101307914 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs569139838 | chr9:101307987-101307988 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs58087887 | chr9:101307993-101307994 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs551816681 | chr9:101308011-101308012 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs571705182 | chr9:101308025-101308026 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs375964185 | chr9:101308052-101308053 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs577765823 | chr9:101308074-101308075 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs1999498 | chr9:101308111-101308112 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
28 | rs375120196 | chr9:101308132-101308133 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs191322216 | chr9:101308153-101308154 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs111303309 | chr9:101308156-101308157 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs186911000 | chr9:101308168-101308169 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs576343500 | chr9:101308176-101308177 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs142673078 | chr9:101308227-101308228 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs558802752 | chr9:101308234-101308235 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs79328959 | chr9:101308339-101308340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs78689511 | chr9:101308340-101308341 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs534037283 | chr9:101308419-101308420 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs577266573 | chr9:101308431-101308432 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs539838427 | chr9:101308475-101308476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs543130722 | chr9:101308491-101308492 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs560202838 | chr9:101308504-101308505 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs200863357 | chr9:101308538-101308539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs573608326 | chr9:101308609-101308610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs147542106 | chr9:101308612-101308613 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs200444321 | chr9:101308669-101308670 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs540480569 | chr9:101308693-101308694 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs190667793 | chr9:101308699-101308700 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs138520381 | chr9:101308711-101308712 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs142001800 | chr9:101308757-101308758 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs565166086 | chr9:101308824-101308825 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Medulloblastoma | 21979893 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Myelofibrosis | 22110671 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Leukemia | 17361228 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Glioblastoma | 16823260 | CNVD |
Leukemia | 18688285 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Brain cancer | 20823417 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Heart disease | 21282601 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral cancer | 21386901 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Gastric cancer | 17908304 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Biliary cancer | 19435499 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Cardiac fibroma | 18329553 | CNVD |
Breast cancer | 17133270 | CNVD |
Basal cell nevus syndrome | 21572526 | CNVD |
Mental retardation | 19951919 | CNVD |
Retinoblastoma | 22278416 | CNVD |
9q22.3 microdeletion syndrome | 22283845 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
overgrowth syndrome | 16570072 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Nicotine dependence | 17160897 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Esophageal cancer | 21851588 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:101304400-101311800 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
2 | chr9:101307200-101307800 | Bivalent Enhancer | Ganglion Eminence derived primary cultured neurospheres | brain |
3 | chr9:101307200-101308200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
4 | chr9:101308200-101311800 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
5 | chr9:101311800-101312000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr9:101311800-101312000 | Enhancers | HSMM | muscle |
7 | chr9:101311800-101312200 | Enhancers | Brain Dorsolateral Prefrontal Cortex | brain |
8 | chr9:101311800-101315400 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
9 | chr9:101311800-101316600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
10 | chr9:101312000-101314000 | Enhancers | NH-A | brain |
11 | chr9:101312200-101312400 | Bivalent Enhancer | Ganglion Eminence derived primary cultured neurospheres | brain |
12 | chr9:101312200-101313000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
13 | chr9:101312200-101313800 | Weak transcription | Brain Dorsolateral Prefrontal Cortex | brain |